newsfilter
← Latest News
GlobeNewswire·

Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

LEXINGTON, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (NASDAQ:KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a